rs56309853
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000055.4(BCHE):c.155C>T(p.Thr52Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 1,613,890 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T52T) has been classified as Likely benign.
Frequency
Consequence
NM_000055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.155C>T | p.Thr52Met | missense_variant | 2/4 | ENST00000264381.8 | |
BCHE | NR_137636.2 | n.273C>T | non_coding_transcript_exon_variant | 2/5 | |||
BCHE | NR_137635.2 | n.110+6435C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BCHE | ENST00000264381.8 | c.155C>T | p.Thr52Met | missense_variant | 2/4 | 1 | NM_000055.4 | P1 | |
LINC01322 | ENST00000651449.1 | n.1008-15013G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? AF: 0.000243 AC: 37AN: 152102Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251192Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135748
GnomAD4 exome AF: 0.000362 AC: 529AN: 1461670Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 264AN XY: 727124
GnomAD4 genome ? AF: 0.000243 AC: 37AN: 152220Hom.: 1 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74424
ClinVar
Submissions by phenotype
Deficiency of butyrylcholinesterase Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Feb 23, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 05, 2023 | Variant summary: BCHE c.155C>T (p.Thr52Met) results in a non-conservative amino acid change located in the Carboxylesterase, type B domain (IPR002018) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 251192 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in BCHE causing Deficiency Of Butyrylcholine Esterase (0.00017 vs 0.016), allowing no conclusion about variant significance. c.155C>T has been reported in the literature as a non-informative (second allele not specified) genotype in at-least two individuals in affected with diminished activity of serum Of Butyrylcholine Esterase in whom hepatic dysfunction was reportedly ruled out (example, Maekawa_1997, subsequently cited by others, example, Brazzolotto_2021). The following publications have been ascertained in the context of this evaluation (PMID: 33024248, 12724618, 9191541, 15781196). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at